2017
DOI: 10.1016/j.jns.2017.03.018
|View full text |Cite
|
Sign up to set email alerts
|

Cefepime-induced encephalopathy in end-stage renal disease patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
18
0
1

Year Published

2017
2017
2022
2022

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 13 publications
(19 citation statements)
references
References 31 publications
0
18
0
1
Order By: Relevance
“…CNS penetration of cefepime may be increased in patients with a previous brain injury. The incidence of CIN in ESRD patients with preexisting CNS morbidity was 22.2%, which is three times higher than that in ESRD patients without previous CNS injury [17]. From the data of a meta-analysis, 8% of the reported patients had preexisting CNS disease [10].…”
Section: Preexisting Brain Injurymentioning
confidence: 91%
See 4 more Smart Citations
“…CNS penetration of cefepime may be increased in patients with a previous brain injury. The incidence of CIN in ESRD patients with preexisting CNS morbidity was 22.2%, which is three times higher than that in ESRD patients without previous CNS injury [17]. From the data of a meta-analysis, 8% of the reported patients had preexisting CNS disease [10].…”
Section: Preexisting Brain Injurymentioning
confidence: 91%
“…The incidence of CIN in a retrospective case-control study in Korean patients was 0.85% [25]. The incidence in ESRD patients was 7.5%, but was 22.2% in ESRD patients with preexisting CNS morbidity [17]. In a recent retrospective study, the incidence of CIN was 0.2% [9].…”
Section: Incidencementioning
confidence: 93%
See 3 more Smart Citations